CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- 4 Exercise or conversion SVP, CFO and Secretary acquired 6,000 shares (option exercise)
- 4 Open-market sale Sr VP & Chief Business Officer sold 500 shares at $24.10 ($12,050)
- 4 Open-market sale Sr VP & Chief Business Officer sold 500 shares at $23.35 ($11,675)
- 4 Open-market sale Sr VP & Chief Business Officer sold 1,500 shares at $20.69 ($31,035)
- 4 Open-market sale Sr VP & Chief Business Officer sold 500 shares at $25.33 ($12,665)
- 4 Open-market sale Sr VP, Research & CSO sold 62,851 shares at an average $30.50 ($1,916,867)
- 4 Open-market sale Director sold 20,773 shares at $27.11 ($563,156)
- 4 Open-market sale Sr VP & Chief Business Officer sold 500 shares at $27.10 ($13,550)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Sr VP & Chief Business Officer sold 500 shares at $28.49 ($14,245)
- 4 Open-market sale Sr VP & Chief Business Officer sold 500 shares at $26.59 ($13,295)
- 4 Open-market sale Sr VP, BPD & Manufacturing sold 7,500 shares at $25.30 ($189,750)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 25 · 484 filings